FDA Inspection 1011944 — Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd.
The FDA completed an inspection of Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd. on May 12, 2017 in Foshan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 12, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Foshan (China)